Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non–small Cell Lung Cancer

PURPOSE: The clinical potential of liquid biopsy in patients with advanced cancer is real-time monitoring for early detection of treatment failure. Our study aimed to investigate the clinical validity of circulating tumor DNA (ctDNA) treatment monitoring in a real-life cohort of patients with advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Frank, Malene S., Andersen, Christina S.A., Ahlborn, Lise B., Pallisgaard, Niels, Bodtger, Uffe, Gehl, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035379/
https://www.ncbi.nlm.nih.gov/pubmed/36969747
http://dx.doi.org/10.1158/2767-9764.CRC-22-0258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035379/
https://www.ncbi.nlm.nih.gov/pubmed/36969747
http://dx.doi.org/10.1158/2767-9764.CRC-22-0258

Ejemplares similares